Esperion Therapeutics Stock Technical Analysis
ESPR Stock | USD 1.91 0.04 2.05% |
As of the 23rd of April, Esperion Therapeutics shows the Mean Deviation of 4.36, variance of 31.45, and Standard Deviation of 5.61. Esperion Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Esperion Therapeutics, which can be compared to its peers. Please confirm Esperion Therapeutics information ratio and kurtosis to decide if Esperion Therapeutics is priced favorably, providing market reflects its regular price of 1.91 per share. Please also check Esperion Therapeutics jensen alpha, which is currently at (0.35) to verify the company can sustain itself at a future point.
Esperion Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Esperion, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EsperionEsperion |
Esperion Therapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
11.13 | Buy | 8 | Odds |
Most Esperion analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Esperion stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Esperion Therapeutics, talking to its executives and customers, or listening to Esperion conference calls.
Esperion Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Esperion Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Esperion Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Esperion Therapeutics Trend Analysis
Use this graph to draw trend lines for Esperion Therapeutics. You can use it to identify possible trend reversals for Esperion Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Esperion Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Esperion Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Esperion Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0006 , which may suggest that Esperion Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.02, which is the sum of squared deviations for the predicted Esperion Therapeutics price change compared to its average price change.About Esperion Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Esperion Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Esperion Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Esperion Therapeutics price pattern first instead of the macroeconomic environment surrounding Esperion Therapeutics. By analyzing Esperion Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Esperion Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Esperion Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2023 | 2024 (projected) | Dividend Yield | 0.38 | 0.34 | Price To Sales Ratio | 2.65 | 2.52 |
Esperion Therapeutics April 23, 2024 Technical Indicators
Most technical analysis of Esperion help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Esperion from various momentum indicators to cycle indicators. When you analyze Esperion charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.02) | |||
Market Risk Adjusted Performance | (0.25) | |||
Mean Deviation | 4.36 | |||
Coefficient Of Variation | (2,151) | |||
Standard Deviation | 5.61 | |||
Variance | 31.45 | |||
Information Ratio | (0.06) | |||
Jensen Alpha | (0.35) | |||
Total Risk Alpha | (0.96) | |||
Treynor Ratio | (0.26) | |||
Maximum Drawdown | 24.09 | |||
Value At Risk | (9.35) | |||
Potential Upside | 8.53 | |||
Skewness | (0.13) | |||
Kurtosis | 0.4252 |
Esperion Therapeutics April 23, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Esperion stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 316,217 | ||
Daily Balance Of Power | (0.31) | ||
Rate Of Daily Change | 0.98 | ||
Day Median Price | 1.91 | ||
Day Typical Price | 1.91 | ||
Price Action Indicator | (0.02) |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Esperion Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Esperion Stock analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Esperion Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Esperion Therapeutics. If investors know Esperion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Esperion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.03) | Revenue Per Share 1.128 | Quarterly Revenue Growth 0.714 | Return On Assets (0.43) | Return On Equity (2.61) |
The market value of Esperion Therapeutics is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Esperion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Therapeutics' market value can be influenced by many factors that don't directly affect Esperion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Esperion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.